Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules
/in Colorectal Cancer, International Publications /von 2005-04-15 / Clin. Cancer Res. 2005 Apr;11(8):3017-24Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity
/in Dendritic Cells, International Publications /von 2005-04-04 / J. Leukoc. Biol. 2005 Aug;78(2):319-24Targeting vaccinia to solid tumors with local hyperthermia
/in Hyperthermia, International Publications, Newcastle Disease Virus /von 2005-04-01 / Hum. Gene Ther. 2005 Apr;16(4):435-44Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2005-04-01 / J. Neurooncol. 2005 Apr;72(2):107-13
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution